Literature DB >> 4596518

Plague immunization. V. Indirect evidence for the efficacy of plague vaccine.

D C Cavanaugh, B L Elisberg, C H Llewellyn, J D Marshall, J H Rust, J E Williams, K F Meyer.   

Abstract

Mesh：

Substances：

Year:  1974        PMID： 4596518     DOI： 10.1093/infdis/129.supplement_1.s37

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  20 in total

1.  Advice to travelers.

Authors:  E Barrett-Connor
Journal:  West J Med       Date:  1975-07

2.  Development of a vaccinia virus based reservoir-targeted vaccine against Yersinia pestis.

Authors:  Debaditya Bhattacharya; Joan Mecsas; Linden T Hu
Journal:  Vaccine       Date:  2010-09-25       Impact factor: 3.641

Review 3.  Developing live vaccines against plague.

Authors:  Wei Sun; Kenneth L Roland; Roy Curtiss
Journal:  J Infect Dev Ctries       Date:  2011-09-14       Impact factor: 0.968

4.  Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge.

Authors:  G P Andrews; D G Heath; G W Anderson; S L Welkos; A M Friedlander
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

5.  Prevention of pneumonic plague in mice, rats, guinea pigs and non-human primates with clinical grade rV10, rV10-2 or F1-V vaccines.

Authors:  Lauriane E Quenee; Nancy A Ciletti; Derek Elli; Timothy M Hermanas; Olaf Schneewind
Journal:  Vaccine       Date:  2011-07-16       Impact factor: 3.641

6.  Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis.

Authors:  G W Anderson; S E Leary; E D Williamson; R W Titball; S L Welkos; P L Worsham; A M Friedlander
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

7.  Potency of killed plague vaccines prepared from avirulent Yersinia pestis.

Authors:  J E Williams; P L Altieri; S Berman; J P Lowenthal; D C Cavanaugh
Journal:  Bull World Health Organ       Date:  1980       Impact factor: 9.408

8.  Human immune response to a plague vaccine comprising recombinant F1 and V antigens.

Authors:  E D Williamson; H C Flick-Smith; C Lebutt; C A Rowland; S M Jones; E L Waters; R J Gwyther; J Miller; P J Packer; M Irving
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

9.  Protective immunity against a lethal respiratory Yersinia pestis challenge induced by V antigen or the F1 capsular antigen incorporated into adenovirus capsid.

Authors:  Julie L Boyer; Carolina Sofer-Podesta; John Ang; Neil R Hackett; Maria J Chiuchiolo; Svetlana Senina; David Perlin; Ronald G Crystal
Journal:  Hum Gene Ther       Date:  2010-07       Impact factor: 5.695

10.  Flagellin-F1-V fusion protein is an effective plague vaccine in mice and two species of nonhuman primates.

Authors:  Steven B Mizel; Aaron H Graff; Nammalwar Sriranganathan; Sean Ervin; Cynthia J Lees; Mark O Lively; Roy R Hantgan; Michael J Thomas; James Wood; Brian Bell
Journal:  Clin Vaccine Immunol       Date:  2008-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.